Blauhut B., Necek S., Kramar H., Vinazzer H., Bergmann H.Activity of antithrombin III and effect of heparin on coagulation in shock . Thromb Res1980;19:775-82.
2.
Blauhut B., Necek S., Vinazzer H., Bergmann H.Substitution therapy with an antithrombin III concentrate in shock and DIC . Thromb Res1982;27:271-8.
3.
Blauhut B., Kramar H., Vinazzer H., Bergmann H.Substitution of antithrombin III in cases of shock and DIC: a randomized study . Thromb Res1985;39:81-9.
4.
Spero JA, Lewis JH, Hasiba U.Disseminated intravascular coagulation: findings in 346 patients. Thromb Haemostas1980;43:28-33.
5.
Aasen AO, Smith-Erichsen N., Amundsen E.Studies on pathological plasma proteolysis in patients with septicemia. Scand J Clin Lab Invest1985;45(suppl 178):37-45.
6.
Seitz R., Wolff M., Egbring R., Havemann K.Substitution of AT III and plasma in septic shock: effect on proteolysis and survival. Haemostasis1988;18(suppl 2):7-8.
7.
Vinazzer H., Blauhut B., Bergmann H.Further experience with AT III substitution in shock and DIC. Thromb Res1986;suppl 6:131.
8.
Hellgren M., Javelin L., Hägnevik K., Blombäck M., Medén-Britth G.Antithrombin III concentrate as adjuvant in DIC treatment: a pilot study in nine severely ill patients. Thromb Res1984 ;35:459-66.
9.
Kreuz WDAntithrombin III substitution therapy in children with acquired AT III deficiency . In: Breddin HK, Bender N, Scharf RE, eds. Recent advances and new developments in hemostaseology. Basel: Karger, 1986:105.
